Literature DB >> 153714

Development of pulmonary arterial changes in rats fed Crotalaria spectabilis.

B Meyrick, L Reid.   

Abstract

The early changes in pulmonary artery structure and the timing and development of right ventricular hypertrophy were examined in rats after ingestion of Crotalaria spectabilis; the arteries were distended with a Micropaque--gelatin mixture. The earliest change, detected at Day 3, is the appearance of new muscle in normally nonmuscular arteries. Increased medial wall thickness of the normally muscular arteries is apparent from Day 7, reaching significance in the smaller arteries from Day 10 and in the larger arteries from Day 14. A reduction in number of small, filled peripheral arteries is apparent at Day 14 and is significant at Day 21 as is the increase in the ratio of alveoli to arteries per unit area of section. Right ventricular hypertrophy is detected and significant at Day 21 and, like all the arterial changes, continues to increase to Day 35. Hypoxia produces similar changes to those described above, although without the inflammation seen after Crotalaria ingestion, but the time table is different. New muscle appears in both models at the same time, but the other changes appear more slowly after ingestion of Crotalaria spectabilis.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 153714      PMCID: PMC2042219     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  17 in total

1.  THE TERMINAL PORTION OF THE PULMONARY ARTERIAL TREE IN PEOPLE NATIVE TO HIGH ALTITUDES.

Authors:  J ARIAS-STELLA; M SALDANA
Journal:  Circulation       Date:  1963-11       Impact factor: 29.690

2.  Pulmonary arteritis produced in rat by feeding Crotalaria spectabilis.

Authors:  J J LALICH; L MERKOW
Journal:  Lab Invest       Date:  1961 Jul-Aug       Impact factor: 5.662

3.  The pulmonary circulation in cystic fibrosis.

Authors:  D Ryland; L Reid
Journal:  Thorax       Date:  1975-06       Impact factor: 9.139

4.  Ventricular weight in cardiac hypertrophy.

Authors:  R M FULTON; E C HUTCHINSON; A M JONES
Journal:  Br Heart J       Date:  1952-07

5.  Right ventricular hypertrophy in monocrotaline pyrrole treated rats.

Authors:  C F Chesney; J R Allen; I C Hsu
Journal:  Exp Mol Pathol       Date:  1974-04       Impact factor: 3.362

6.  Pulmonary arterial muscularity and right ventricular hypertrophy in chronic bronchitis and emphysema.

Authors:  M Semmens; L Reid
Journal:  Br J Dis Chest       Date:  1974-10

7.  The effect of continued hypoxia on rat pulmonary arterial circulation. An ultrastructural study.

Authors:  B Meyrick; L Reid
Journal:  Lab Invest       Date:  1978-02       Impact factor: 5.662

8.  Changes in the pulmonary arteries of the rat during recovery from hypoxia-induced pulmonary hypertension.

Authors:  A Hislop; L Reid
Journal:  Br J Exp Pathol       Date:  1977-12

9.  Fibrin thrombosis in monocrotaline pyrrole-induced cor pulmonale in rats.

Authors:  J L Lalich; W D Johnson; T J Raczniak; R C Shumaker
Journal:  Arch Pathol Lab Med       Date:  1977-02       Impact factor: 5.534

10.  New findings in pulmonary arteries of rats with hypoxia-induced pulmonary hypertension.

Authors:  A Hislop; L Reid
Journal:  Br J Exp Pathol       Date:  1976-10
View more
  24 in total

1.  Monocrotaline-induced structural remodeling of the intra-acinar pulmonary arteries and pulmonary hypertension.

Authors:  W Y Li; D Y Che
Journal:  J Tongji Med Univ       Date:  1992

2.  Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension.

Authors:  R M Tuder; B Groves; D B Badesch; N F Voelkel
Journal:  Am J Pathol       Date:  1994-02       Impact factor: 4.307

3.  Management of primary pulmonary hypertension.

Authors:  C M Oakley
Journal:  Br Heart J       Date:  1985-01

Review 4.  The structural basis of pulmonary hypertension in chronic lung disease: remodelling, rarefaction or angiogenesis?

Authors:  Natalie Hopkins; Paul McLoughlin
Journal:  J Anat       Date:  2002-10       Impact factor: 2.610

5.  Contribution of oxidative stress to pulmonary arterial hypertension.

Authors:  Vincent G Demarco; Adam T Whaley-Connell; James R Sowers; Javad Habibi; Kevin C Dellsperger
Journal:  World J Cardiol       Date:  2010-10-26

6.  Increased TMEM16A-encoded calcium-activated chloride channel activity is associated with pulmonary hypertension.

Authors:  Abigail S Forrest; Talia C Joyce; Marissa L Huebner; Ramon J Ayon; Michael Wiwchar; John Joyce; Natalie Freitas; Alison J Davis; Linda Ye; Dayue D Duan; Cherie A Singer; Maria L Valencik; Iain A Greenwood; Normand Leblanc
Journal:  Am J Physiol Cell Physiol       Date:  2012-10-03       Impact factor: 4.249

7.  Ultrastructural findings in lung biopsy material from children with congenital heart defects.

Authors:  B Meyrick; L Reid
Journal:  Am J Pathol       Date:  1980-12       Impact factor: 4.307

8.  Semotiadil inhibits the development of right ventricular hypertrophy and medial thickening of pulmonary arteries in a rat model of pulmonary hypertension.

Authors:  T Takahashi; T Kanda; S Imai; T Suzuki; I Kobayashi; K Murata
Journal:  Cardiovasc Drugs Ther       Date:  1995-12       Impact factor: 3.727

9.  Failure to show decrease in small pulmonary blood vessels in rats with experimental pulmonary hypertension.

Authors:  J M Kay; K L Suyama; P M Keane
Journal:  Thorax       Date:  1982-12       Impact factor: 9.139

10.  Needs for animal models of human diseases of the respiratory system.

Authors:  L M Reid
Journal:  Am J Pathol       Date:  1980-12       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.